Daiken Medical Co., Ltd. (TYO:7775)
Japan · Delayed Price · Currency is JPY 470.00
+1.00 (0.21%)
Jan 23, 2026, 3:30 PM JST
Daiken Medical Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | 1,346 | 1,508 | 1,436 | 1,025 | 1,151 | 944 | Upgrade |
Depreciation & Amortization | 243 | 232 | 214 | 267 | 314 | 256 | Upgrade |
Loss (Gain) From Sale of Assets | 2 | 2 | 5 | 28 | 1 | - | Upgrade |
Other Operating Activities | -389 | -445 | -436 | -377 | -219 | -326 | Upgrade |
Change in Accounts Receivable | -59 | 8 | 50 | -99 | 156 | 138 | Upgrade |
Change in Inventory | -175 | 7 | 76 | 29 | -122 | -248 | Upgrade |
Change in Accounts Payable | -106 | -126 | 120 | 113 | -71 | -266 | Upgrade |
Change in Other Net Operating Assets | -2 | -66 | 90 | 3 | -77 | 111 | Upgrade |
Operating Cash Flow | 860 | 1,120 | 1,555 | 989 | 1,133 | 609 | Upgrade |
Operating Cash Flow Growth | -39.69% | -27.97% | 57.23% | -12.71% | 86.04% | -57.59% | Upgrade |
Capital Expenditures | -234 | -166 | -162 | -198 | -202 | -309 | Upgrade |
Sale (Purchase) of Intangibles | -1 | -1 | -6 | -1 | - | -3 | Upgrade |
Other Investing Activities | -4 | -1 | - | -11 | 6 | 1 | Upgrade |
Investing Cash Flow | -239 | -168 | -168 | -210 | -196 | -311 | Upgrade |
Short-Term Debt Issued | - | - | 80 | - | - | 200 | Upgrade |
Long-Term Debt Issued | - | 750 | - | 400 | 700 | 800 | Upgrade |
Total Debt Issued | - | 750 | 80 | 400 | 700 | 1,000 | Upgrade |
Short-Term Debt Repaid | - | -360 | - | - | - | - | Upgrade |
Long-Term Debt Repaid | - | -465 | -659 | -604 | -704 | -908 | Upgrade |
Total Debt Repaid | -789 | -825 | -659 | -604 | -704 | -908 | Upgrade |
Net Debt Issued (Repaid) | -789 | -75 | -579 | -204 | -4 | 92 | Upgrade |
Common Dividends Paid | -669 | -612 | -573 | -565 | -574 | -574 | Upgrade |
Other Financing Activities | -7 | -9 | -11 | -12 | -11 | -10 | Upgrade |
Financing Cash Flow | -1,465 | -696 | -1,163 | -781 | -589 | -492 | Upgrade |
Miscellaneous Cash Flow Adjustments | -1 | - | -2 | - | -1 | - | Upgrade |
Net Cash Flow | -845 | 256 | 222 | -2 | 347 | -194 | Upgrade |
Free Cash Flow | 626 | 954 | 1,393 | 791 | 931 | 300 | Upgrade |
Free Cash Flow Growth | -51.81% | -31.51% | 76.11% | -15.04% | 210.33% | -76.43% | Upgrade |
Free Cash Flow Margin | 6.20% | 9.59% | 14.29% | 8.66% | 10.90% | 3.82% | Upgrade |
Free Cash Flow Per Share | 21.79 | 33.21 | 48.49 | 27.53 | 32.41 | 10.44 | Upgrade |
Cash Interest Paid | 11 | 10 | 4 | 3 | 3 | 3 | Upgrade |
Cash Income Tax Paid | 388 | 443 | 438 | 379 | 218 | 325 | Upgrade |
Levered Free Cash Flow | 495.5 | 776.38 | 1,261 | 776.5 | 802.5 | 72.75 | Upgrade |
Unlevered Free Cash Flow | 502.38 | 782 | 1,264 | 778.38 | 804.38 | 74.63 | Upgrade |
Change in Working Capital | -342 | -177 | 336 | 46 | -114 | -265 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.